Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Alessandro Vagheggini"'
Autor:
Luigi Pasini, Michela Notarangelo, Alessandro Vagheggini, Marco Angelo Burgio, Lucio Crinò, Elisa Chiadini, Andrea Iamurri Prochowski, Angelo Delmonte, Paola Ulivi, Vito Giuseppe D'Agostino
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2423-2438 (2021)
The mutational status of the epidermal growth factor receptor (EGFR) guides the stratification of non‐small cell lung cancer (NSCLC) patients for treatment with tyrosine kinase inhibitors (TKIs). A liquid biopsy test on cell‐free DNA is recommend
Externí odkaz:
https://doaj.org/article/a104101c872849d4aae38dc98179fc13
Autor:
Silvia De Padova, Luigi Grassi, Alessandro Vagheggini, Martino Belvederi Murri, Federica Folesani, Lorena Rossi, Alberto Farolfi, Tatiana Bertelli, Alessandro Passardi, Alejandra Berardi, Ugo De Giorgi
Publikováno v:
Cancer Medicine, Vol 10, Iss 12, Pp 3974-3985 (2021)
Abstract Background The experience of cancer is highly stressful and potentially traumatic. We assessed the presence of Post‐Traumatic Stress Symptoms (PTSS) in long‐term cancer survivors and their caregivers, while examining the association betw
Externí odkaz:
https://doaj.org/article/8077b603931f405b91ea63d4e83ddbe9
Autor:
Alberto Bongiovanni, Chiara Liverani, Federica Recine, Valentina Fausti, Laura Mercatali, Alessandro Vagheggini, Chiara Spadazzi, Giacomo Miserocchi, Claudia Cocchi, Giandomenico Di Menna, Alessandro De Vita, Stefano Severi, Silvia Nicolini, Toni Ibrahim
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Several phase-II trials have been designed to evaluate tyrosine kinase inhibitors (TKIs), in particular, pazopanib in neuroendocrine neoplasia (NEN), but its efficacy has not yet been demonstrated in a randomised-controlled Phase III tria
Externí odkaz:
https://doaj.org/article/4b1b34e9a54d4ffeba6e151454ff1b8e
Autor:
Concetta Saponaro, Alessandro Vagheggini, Emanuela Scarpi, Matteo Centonze, Ivana Catacchio, Ondina Popescu, Maria Irene Pastena, Francesco Giotta, Nicola Silvestris, Anita Mangia
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 37, Iss 1, Pp 1-16 (2018)
Abstract Background Tumor microenvironment (TME) includes many factors such as tumor associated inflammatory cells, vessels, and lymphocytes, as well as different signaling molecules and extracellular matrix components. These aspects can be de-regula
Externí odkaz:
https://doaj.org/article/b46680c76e6f4ffe9323be2ac050cf99
Autor:
Anna Sarnelli, Emilio Mezzenga, Alessandro Vagheggini, Filippo Piccinini, Giacomo Feliciani, Maria Luisa Belli, Francesco Monti, Marta Cremonesi, Corrado Cittanti, Giovanni Martinelli, Giovanni Paganelli
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0218814 (2019)
The purpose of this study was to apply texture analysis (TA) to evaluate the uniformity of SPECT images reconstructed with the 3D Ordered Subsets Expectation Maximization (3D-OSEM) algorithm. For this purpose, a cylindrical homogeneous phantom filled
Externí odkaz:
https://doaj.org/article/37766578fe2e4190a5e7459c17fe1cc6
Autor:
Alessandro Savini, Giacomo Feliciani, Michele Amadori, Stefano Rivetti, Marta Cremonesi, Francesco Cesarini, Tiziana Licciardello, Daniela Severi, Valentina Ravaglia, Alessandro Vagheggini, Anna Sarnelli, Fabio Falcini
Publikováno v:
Applied Sciences, Vol 10, Iss 17, p 6047 (2020)
Background: Digital breast tomosynthesis (DBT) systems employ a sophisticated set of acquisition parameters to generate an image set, and the DBT acquisition angle is considered to be one of the most important parameters. The aim of this study was to
Externí odkaz:
https://doaj.org/article/a3fb4cb140c64bee875d0ca5018190b9
Autor:
Michela Palleschi, Roberta Maltoni, Sara Ravaioli, Alessandro Vagheggini, Francesca Mannozzi, Francesca Fanini, Francesca Pirini, Maria Maddalena Tumedei, Eleonora Barzotti, Lorenzo Cecconetto, Samanta Sarti, Silvia Manunta, Paola Possanzini, Anna Fedeli, Annalisa Curcio, Mattia Altini, Ugo De Giorgi, Andrea Rocca, Sara Bravaccini
Publikováno v:
Diagnostics, Vol 10, Iss 8, p 573 (2020)
CDK4/6 inhibitors (CDK4/6i) are recommended in patients with estrogen receptor (ER)-positive, HER2-negative advanced breast cancer (ABC). Up to now, no prognostic biomarkers have been identified in this setting. We retrospectively analyzed the expres
Externí odkaz:
https://doaj.org/article/0adf67f7810c4db9830a1083bd264157
Autor:
Martino Belvederi Murri, Silvia De Padova, Luigi Grassi, Alessandro Vagheggini, Lorena Rossi, Federica Folesani, Ugo De Giorgi, Alejandra Berardi, Tatiana Bertelli, Alberto Farolfi, Alessandro Passardi
Publikováno v:
Cancer Medicine, Vol 10, Iss 12, Pp 3974-3985 (2021)
Cancer Medicine
Cancer Medicine
Background The experience of cancer is highly stressful and potentially traumatic. We assessed the presence of Post‐Traumatic Stress Symptoms (PTSS) in long‐term cancer survivors and their caregivers, while examining the association between PTSS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20caf813a885762108ea48cf31155fbf
https://doaj.org/article/8077b603931f405b91ea63d4e83ddbe9
https://doaj.org/article/8077b603931f405b91ea63d4e83ddbe9
Autor:
Paola Ulivi, Andrea Iamurri Prochowski, Vito Giuseppe D'Agostino, Marco Angelo Burgio, Lucio Crinò, Alessandro Vagheggini, Elisa Chiadini, Michela Notarangelo, Luigi Pasini, Angelo Delmonte
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2423-2438 (2021)
Molecular Oncology
Molecular Oncology
The mutational status of the epidermal growth factor receptor (EGFR) guides the stratification of non‐small cell lung cancer (NSCLC) patients for treatment with tyrosine kinase inhibitors (TKIs). A liquid biopsy test on cell‐free DNA is recommend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32ce7cacb76deabca15e5aff8feb00da
Wiley Online Library
Wiley Online Library
Autor:
Alessandro Vagheggini, Roberta Maltoni, Michela Palleschi, Paola Possanzini, Eleonora Barzotti, Anna Fedeli, Sara Bravaccini, Silvia Manunta, Andrea Rocca, Lorenzo Cecconetto, Mattia Altini, Francesca Mannozzi, Annalisa Curcio, Sara Ravaioli, Francesca Pirini, Samanta Sarti, Ugo De Giorgi, Maria Maddalena Tumedei, Francesca Fanini
Publikováno v:
Diagnostics
Diagnostics, Vol 10, Iss 573, p 573 (2020)
Volume 10
Issue 8
Diagnostics, Vol 10, Iss 573, p 573 (2020)
Volume 10
Issue 8
CDK4/6 inhibitors (CDK4/6i) are recommended in patients with estrogen receptor (ER)-positive, HER2-negative advanced breast cancer (ABC). Up to now, no prognostic biomarkers have been identified in this setting. We retrospectively analyzed the expres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c997b77754c122f2021cb44e3596faa
https://pubmed.ncbi.nlm.nih.gov/32784518
https://pubmed.ncbi.nlm.nih.gov/32784518